4uye
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide== | ==BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide== | ||
<StructureSection load='4uye' size='340' side='right' caption='[[4uye]], [[Resolution|resolution]] 1.65Å' scene=''> | <StructureSection load='4uye' size='340' side='right' caption='[[4uye]], [[Resolution|resolution]] 1.65Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9F9:N-[1,3-DIMETHYL-2-OXO-6-(PIPERIDIN-1-YL)-2,3-DIHYDRO-1H-BENZIMIDAZOL-5-YL]-2-METHOXYBENZAMIDE'>9F9</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9F9:N-[1,3-DIMETHYL-2-OXO-6-(PIPERIDIN-1-YL)-2,3-DIHYDRO-1H-BENZIMIDAZOL-5-YL]-2-METHOXYBENZAMIDE'>9F9</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4uyd|4uyd]], [[4uyf|4uyf]], [[4uyg|4uyg]], [[4uyh|4uyh]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4uyd|4uyd]], [[4uyf|4uyf]], [[4uyg|4uyg]], [[4uyh|4uyh]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4uye FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uye OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4uye RCSB], [http://www.ebi.ac.uk/pdbsum/4uye PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4uye FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uye OCA], [http://pdbe.org/4uye PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4uye RCSB], [http://www.ebi.ac.uk/pdbsum/4uye PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4uye ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 17: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4uye" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 01:20, 19 January 2017
BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide
| |||||||||||
